• Taliglucerase Alfa Therapy Seen as Safe and Effective for Children with Gaucher Disease Type 1, Review Finds
  • Gaucher Initiative in Egypt, UnitedHealth Group Recognized at Project HOPE’s Annual NYC Gala
  • Introduction of Enzyme Replacement Therapy with Cerezyme Has Significantly Decreased Severe GD1 Complications, Study Shows
  • Different Mutations in Gaucher Disease May Be Linked to Development of Parkinson’s
  • England’s National Health Service to Make Cerdelga Available as Gaucher Therapy
  • Cerdelga Improves Gastrointestinal Symptoms in GD Patient, Korean Case Report Shows
  • Earlier Diagnosis of Gaucher in Children Reduces Incidence of Severe Disease, Study Says
  • Good Start Genetics’ VeriYou to Offer Ashkenazi Jewish Carrier Screening Test for Multiple Disorders
  • Sales of Protalix’s Gaucher Therapy Elelyso Increase Substantially This Year
  • The Assistance Fund Now Provides Financial Help for Gaucher Patients, Families
  • Health Canada Approves Sanofi Genzyme’s Cerdelga to Treat Gaucher Disease Type 1
  • PPMI Clinical Trial Seeks to Uncover Link Between GBA Mutations and Parkinson’s